Lee's Pharmaceutical Holdings Limited (LPCUF) Investment Research Dashboard
About Lee's Pharmaceutical Holdings Limited (LPCUF) stock analysis
Get live LPCUF stock price $0.19, comprehensive Lee's Pharmaceutical Holdings Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time LPCUF stock data and investment insights.
Loading chart data...
Lee's Pharmaceutical Holdings Limited (LPCUF) Overview
Lee's Pharmaceutical Holdings Limited (LPCUF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, LPCUF trades at $0.19 with a market capitalization of 110.82M . Over the past 52 weeks, LPCUF has traded between $0.19 and $0.20 , with the current price positioned at approximately 0% ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 110.82M
- Current price: $0.19
- 52-week range: $0.19 - $0.20
- P/E ratio: 4.85
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Lee's Pharmaceutical Holdings Limited functions as an investment holding company primarily focused on the development, manufacturing, and commercialization of pharmaceutical products within the People's Republic of China. The company's therapeutic sc...
Company Information
- CEO
- Siu Fong Lee
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1094
Contact Information
- Website
- https://www.leespharm.com
- Address
- Building 20E
- Country
- HK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 4.8)
✓ Lower volatility stock (Beta: 0.57) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Lee's Pharmaceutical Holdings Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Lee's Pharmaceutical Holdings Limited
- ⚠Investors should consider how Lee's Pharmaceutical Holdings Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
110.82M
P/E Ratio (TTM)
4.85
Beta
0.57
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LPCUF with peer companies:
- Price
- $8.87+0.00% (1D)
- Market cap
- 103.66M
- Price
- $5.70+0.00% (1D)
- Market cap
- 120.50M
- Price
- $6.30+0.00% (1D)
- Market cap
- 109.16M
- Price
- $0.12+0.00% (1D)
- Market cap
- 131.72M
- Price
- $2.00+0.00% (1D)
- Market cap
- 169.26M
- Price
- $3.04+0.00% (1D)
- Market cap
- 108.29M
- Price
- $0.01-14.49% (1D)
- Market cap
- 86.42K
- Price
- $5.00+0.00% (1D)
- Market cap
- 131.77M
- Price
- $37.00+0.00% (1D)
- Market cap
- 114.90M
- Price
- $0.15+0.00% (1D)
- Market cap
- 117.53M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.